表紙
市場調查報告書

敗血症治療藥的全球市場

Sepsis Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 210344
出版日期 內容資訊 英文 66 Pages
商品交期: 最快1-2個工作天內
價格
敗血症治療藥的全球市場 Sepsis Therapeutics
出版日期: 2020年02月01日內容資訊: 英文 66 Pages
簡介

本報告提供全球敗血症治療藥市場相關調查分析,提供美國及全球其他各國等市場別相關分析,再彙整今後的市場預測,主要企業簡介等相關資訊。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 敗血症治療藥的簡介
    • 敗血症專用治療藥的缺失
    • 開發中止或退出市場的敗血症治療藥候補
    • 競爭和開發平台
    • 用於目前敗血症第一療法之抗生素類別
    • 主要的管線藥:2016年
    • 現在與未來的分析
    • 促進成長要素
    • 市場抑制因素
    • 臨床試驗策略重新評估的必要性
    • 新免疫的作用機構受到關注
    • 藥物抗性的威脅
    • 老年人口統計
  • 敗血症治療藥的創新
  • 敗血症概要
  • 臨床試驗
  • 產品的引進與核准
  • 近來產業活動
  • 全球主要企業
    • Adrenomed AG (德國)
    • AM-Pharma B.V. (荷蘭)
    • Aridis Pharmaceuticals, Inc. (美國)
    • Asahi Kasei Pharma America (美國)
    • Astellas Pharma Inc. (日本)
    • Bristol-Myers Squibb Company (美國)
    • Chong Kun Dang BiO Corp. (韓國)
    • Endacea, Inc. (美國)
    • InflaRx GmbH (德國)
    • Opsona Therapeutics Ltd. (愛爾蘭)
    • Opsonix, Inc. (美國)
    • T2 Biosystems, Inc. (美國)
    • TaiRx, Inc. (美國)
    • TiGenix NV (比利時)
  • 全球市場概要

第3章 市場

  • 美國
  • 全球其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6525

Sepsis Therapeutics market worldwide is projected to grow by US$474.3 Trillion, driven by a compounded growth of 79%. Sepsis Therapeutics, one of the segments analyzed and sized in this study, displays the potential to grow at over 79%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$482.5 Trillion by the year 2025, Sepsis Therapeutics will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 87.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$9.9 Trillion to the region's size and clout in the next 5 to 6 years. Over US$21.2 Trillion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Sepsis Therapeutics will reach a market size of US$26.4 Trillion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 75.1% over the next couple of years and add approximately US$73.2 Trillion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Adrenomed AG
  • AM-Pharma B.V.
  • Aridis Pharmaceuticals Inc.
  • Asahi Kasei Pharma America
  • Astellas Pharma Inc.
  • Chong Kun Dang BiO Corporation
  • Endacea Inc.
  • InflaRx GmbH
  • La Jolla Pharmaceutical Company
  • Opsonix, Inc.
  • T2 Biosystems Inc.
  • TaiRx Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Sepsis - A Prelude
  • Recent Market Activity
  • New Treatment Protocols and New Definitions - Every Minute Counts!!
  • Aging Population: A Key Growth Driver for Sepsis Therapeutics
  • Antibiotics and Vasopressors - The Current Standard of Care
  • Current Categories of Antibacterial Agents for First-line Sepsis Treatment
  • Current Anti-bacterial Drugs used in Sepsis
  • Current Antifungals used for Sepsis
  • Current Antivirals used for Sepsis
  • GIAPREZA - The Only FDA Approved Branded Drug for Sepsis Treatment
  • Argipressin Gains Approval for Septic Shock in 26 EU countries
  • Current & Future Analysis
  • Growth Drivers in a Nutshell
  • Market Restraints
  • Global Competitor Market Shares
  • Sepsis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2020 & 2029

2. FOCUS ON SELECT PLAYERS

  • Adrenomed AG (Germany)
  • AM-Pharma B.V. (Netherlands)
  • AMOMED Pharma GmbH (Austria)
  • Asahi Kasei Pharma America (USA)
  • Endacea, Inc. (USA)
  • InflaRx N.V. (Germany)
  • La Jolla Pharmaceutical Company (USA)
  • TaiRx, Inc. (USA)

3. MARKET TRENDS & DRIVERS

  • A Market Characterized by High Unmet Medical Needs
  • Research Activity Enables Increased Awareness of Disease Pathogenesis
  • Select Sepsis Therapeutics under Phase IV Clinical Trials: As of 2018
  • Select Sepsis Therapeutics under Phase III Clinical Trials: 2018
  • Novel Immune-Specific Modes of Action under Focus
  • Emphasizing on Endothelial Cell Function
  • HMGB1 - A Potential Target for Future Therapies
  • Nanoparticle Systems Demonstrate Potential for Use in Septic Shock Management
  • Researchers Employ IL-7 to Increase CD4 and CD8 Immune Cells in Patients
  • Hydrocortisone Displays Potential in Septic Shock Treatment
  • Reduced Levels of Vitamin C Characterize Sepsis Patients
  • Treatment with Hydrocortisone and Vitamin C Demonstrates Positive Impact on Mortality Rate
  • Intravenous Vitamins + Hydrocortisone Therapy Causes Waves in the Market
  • Researchers Develop ss-Sepsis-3 Protocol for Evaluation of Sepsis in Animal Models
  • World Sepsis Day Aims to Result in Improvement in Sepsis Management
  • NSAIDs Demonstrate Potential to Treat Sepsis

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Sepsis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Sepsis Therapeutics Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • Market Analytics
    • TABLE 3: United States Sepsis Therapeutics Market Estimates and Projections in US$ Million: 2018 to 2025
  • CANADA
    • TABLE 4: Canadian Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018 to 2025
  • JAPAN
    • TABLE 5: Japanese Market for Sepsis Therapeutics: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • CHINA
    • TABLE 6: Chinese Sepsis Therapeutics Market Growth Prospects in US$ Million for the Period 2018-2025
  • EUROPE
    • Market Facts & Figures
    • Market Analytics
    • TABLE 7: European Sepsis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 8: European Sepsis Therapeutics Market Share Shift by Region/Country: 2019 VS 2025
  • FRANCE
    • TABLE 9: Sepsis Therapeutics Market in France: Estimates and Projections in US$ Million for the Period 2018-2025
  • GERMANY
    • TABLE 10: Sepsis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025
  • ITALY
    • TABLE 11: Italian Sepsis Therapeutics Market Growth Prospects in US$ Million for the Period 2018-2025
  • UNITED KINGDOM
    • TABLE 12: United Kingdom Market for Sepsis Therapeutics: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025
  • REST OF EUROPE
    • TABLE 13: Rest of Europe Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018-2025
  • ASIA-PACIFIC
    • TABLE 14: Sepsis Therapeutics Market in Asia-Pacific: Estimates and Projections in US$ Million for the Period 2018-2025
  • REST OF WORLD
    • TABLE 15: Rest of World Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018 to 2025

IV. COMPETITION

  • Total Companies Profiled: 24
  • SEPSIS THERAPEUTICS MCP-6525
  • CONTENTS